Key takeaways
- Both are evidence based treatments for opioid use disorder, and both substantially reduce the risk of overdose death. Neither is a lesser option.
- Suboxone is buprenorphine plus naloxone, a partial opioid agonist. Methadone is a full agonist.
- The practical difference is usually access. Suboxone can be prescribed in an office and filled at a pharmacy. Methadone for opioid use disorder must come from a federally certified opioid treatment program, often with daily visits at first.
- Buprenorphine has a ceiling effect that lowers overdose risk. Methadone has no ceiling, which is part of why it is more tightly regulated and also why it works for some people when buprenorphine does not.
- Staying on medication longer is associated with better outcomes. Stopping early is where most relapses happen.
How Each One Works
Both medications occupy the same opioid receptors that heroin, fentanyl and prescription opioids act on. That is the point. By occupying those receptors steadily, they stop withdrawal and cravings without producing the cycle of intoxication and crash.
Buprenorphine, the active ingredient in Suboxone, is a partial agonist. It activates the receptor only partially, and it has a ceiling: past a certain dose, more does not produce more effect, including more respiratory depression. It also binds very tightly, which blocks other opioids from taking hold. Suboxone adds naloxone, which does essentially nothing when taken as directed and is there to discourage injection.
Methadone is a full agonist with no ceiling. Dosed correctly it produces stability rather than a high, because it is long acting and steady. Because there is no ceiling, dosing has to be careful, particularly at the start.
Neither one is “substituting one addiction for another.” That framing is common and it is wrong. Physical dependence is not the same as addiction, which is defined by compulsive use and harm. Someone stable on either medication is, by any clinical measure, in treatment.
The Side by Side
| Suboxone (buprenorphine/naloxone) | Methadone | |
|---|---|---|
| Type | Partial opioid agonist | Full opioid agonist |
| Where you get it | Office based prescriber, filled at a pharmacy | Federally certified opioid treatment program |
| Typical early schedule | Prescription, often monthly after stabilizing | Often daily on-site dosing at first, with take-homes earned over time |
| Overdose ceiling | Yes, which lowers risk | No ceiling |
| Starting it | Requires waiting until withdrawal has begun, or a specialized low dose start | Started at a low dose and raised slowly |
| Works well when | Most people, including those who need flexibility | High tolerance, long history, or buprenorphine has not held |
Starting Each One
The starting process is where the two differ most, and where people most often get discouraged.
Buprenorphine binds so tightly that if you take it while other opioids are still on the receptors, it can displace them and trigger sudden, severe withdrawal. This is called precipitated withdrawal. Avoiding it traditionally means waiting until you are already in moderate withdrawal before the first dose. Fentanyl has made this harder, because it lingers in body tissue longer than heroin did, and clinicians increasingly use low dose initiation protocols to work around it.
Methadone avoids that problem entirely, since it is a full agonist. The tradeoff is that it must be raised slowly over days to weeks, because the risk window for methadone is early, before tolerance catches up to the dose.
Living With Each One
For most people the deciding factor is not pharmacology, it is logistics and history.
Methadone programs generally require daily attendance at the start, with take-home doses earned over weeks to months of stability. For someone working full time, parenting, or living far from a clinic, that is a real obstacle. For someone who needs external structure, that same requirement is the most useful part of the treatment.
Suboxone fits more easily around work and family, which is why it is often the starting point for professionals and parents. The flexibility cuts both ways: there is less built-in accountability, so the therapy and monitoring around it matter more.
Side effects overlap heavily: constipation, sweating, sleep changes, lowered libido. Methadone carries more interaction cautions, including QT interval effects on the heart, so other medications need review. Buprenorphine’s dental health signal led to an FDA warning about the dissolving forms, which is manageable with rinsing and dental care.
How the Decision Actually Gets Made
A useful assessment asks a handful of questions. How much opioid, how long, and what kind? Has either medication been tried before, and what happened? Is there a stable place to live? What does the day look like, and is daily dosing possible? Are there heart or liver concerns, or other medications in play? Is there a co-occurring mental health condition that needs treating at the same time?
The honest answer is that both work, and the better one is the one a person will actually stay on. Duration is the strongest predictor of outcome in the research. Tapering off too early is consistently where relapse and overdose risk climb, because tolerance drops while the risk environment does not.
At Heights we prescribe buprenorphine and naltrexone as part of outpatient care, and we coordinate with methadone programs when that is the better fit rather than treating it as a lesser path. You can read about our medication assisted treatment, opioid addiction treatment, or fentanyl and heroin treatment.
Heights Behavioral Health is a private-pay, out-of-network provider, and we are clear about pricing before you commit to anything. See how cost and out-of-network benefits work.
If this is an emergency or you are thinking about harming yourself, call 911, or call or text 988 to reach the Suicide and Crisis Lifeline. In Harris County, The Harris Center operates a 24-hour crisis line at 713-970-7000. Heights Behavioral Health is an outpatient program and is not a 24-hour crisis service.
Frequently Asked Questions
Which is stronger, Suboxone or methadone?
Methadone is a full opioid agonist with no ceiling effect, so in pharmacological terms it is stronger. That does not make it better. It makes it more tightly regulated, and it is often the right choice when tolerance is high or buprenorphine has not held.
Why is methadone harder to get than Suboxone?
Methadone for opioid use disorder can only be dispensed through a federally certified opioid treatment program, which usually means attending in person, daily at first. Buprenorphine can be prescribed in an ordinary office visit and filled at a pharmacy.
Can you switch from methadone to Suboxone?
Yes, but it has to be done carefully. Because buprenorphine displaces full agonists from the receptor, switching usually requires tapering methadone to a lower dose first, and it should always be supervised by a clinician.
How long do you stay on these medications?
There is no fixed length, and longer is generally better. Some people use medication for a year, some for many years. The research consistently shows that stopping early raises relapse and overdose risk, so tapering is a clinical decision made with your prescriber.
What is precipitated withdrawal?
Sudden, severe withdrawal triggered when buprenorphine displaces another opioid still on the receptors. It is avoided by waiting until withdrawal has already started before the first dose, or by using a low dose initiation protocol, which has become more common since fentanyl.
Is medication assisted treatment just swapping one addiction for another?
No. Physical dependence is not addiction. Addiction is defined by compulsive use and harm despite consequences. Someone stable on buprenorphine or methadone, working and in relationships, is in treatment, and both medications substantially reduce the risk of dying.
Do you take insurance for medication assisted treatment?
We are a private pay practice. For clients with out of network benefits, we provide detailed superbills you can submit to your insurer for possible reimbursement, and we verify your benefits and explain costs before you commit to anything.
When the Question Becomes a Pattern
If cocaine has become a worry rather than a one-time question, one confidential call can help you understand what help would look like around your life.
Sources
- Substance Abuse and Mental Health Services Administration: Medications for Substance Use Disorders
- National Institute on Drug Abuse: Medications to Treat Opioid Use Disorder Research Report
- World Health Organization: Guidelines for Psychosocially Assisted Pharmacological Treatment of Opioid Dependence
- U.S. Food and Drug Administration: Information about Medication Assisted Treatment
Written and Reviewed by Licensed Clinicians
Joni Ogle is a Licensed Clinical Social Worker (LCSW) and Certified Sex Addiction Therapist (CSAT) with over 37 years of clinical experience in mental health and addiction recovery, dual diagnosis treatment, behavioral addictions, and family intervention. She is the founder of Heights Behavioral Health and Heights Mentoring in Houston, Texas, where she leads a team of licensed clinicians.
Texas LCSW #37376 · Verify license
Deborah Darnell-Drake, LCSW-S, ACSW, LMFT is the Chief Clinical Officer at Heights Behavioral Health and a clinical reviewer. With more than five decades of experience in mental health and substance use disorder treatment, Deborah specializes in addiction, co-occurring mental health conditions, family dynamics, and behavioral addictions including gambling and technology addiction.
Texas LCSW-S #14508 · LMFT #1125 · Verify license
Start a Confidential Conversation
One confidential message connects you with our admissions team and a clear next step. Prefer to talk now? Call (877) 549-5102.
